Sg Americas Securities, LLC Alkermes Plc. Transaction History

Sg Americas Securities, LLC

$24.1 Billion
Q2 2025

A detailed history of Sg Americas Securities, LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 60,842 shares of ALKS stock, worth $1.66 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

60,842

Previous 13,988 334.96%

Holding current value

$1.66 Million

Previous $462,000 276.84%

% of portfolio

0.01%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 08, 2025	BUY	$26.59 - $32.65 $1.25 Million - $1.53 Million	46,854 Added 334.96%	60,842 $1.74 Million
Q1 2025 Apr 15, 2025	BUY	$28.08 - $36.0 $80,645 - $103,392	2,872 Added 25.84%	13,988 $462,000
Q4 2024 Jan 17, 2025	SELL	$25.7 - $31.46 $238,573 - $292,043	-9,283 Reduced 45.51%	11,116 $320,000
Q3 2024 Oct 03, 2024	BUY	$23.01 - $28.55 $469,380 - $582,391	20,399 New	20,399 $571,000
Q1 2024 May 06, 2024	SELL	$26.4 - $32.56 $432,643 - $533,593	-16,388 Reduced 38.73%	25,921 $702,000
Q4 2023 Jan 12, 2024	SELL	$23.37 - $28.68 $2.28 Million - $2.8 Million	-97,624 Reduced 69.76%	42,309 $1.17 Million
Q3 2023 Oct 13, 2023	BUY	$27.17 - $31.97 $3.7 Million - $4.35 Million	136,214 Added 3662.65%	139,933 $3.92 Million
Q2 2023 Jul 10, 2023	SELL	$28.34 - $33.63 $2.33 Million - $2.77 Million	-82,376 Reduced 95.68%	3,719 $116,000
Q1 2023 Apr 28, 2023	BUY	$25.31 - $29.02 $1.8 Million - $2.06 Million	70,993 Added 470.09%	86,095 $2.43 Million
Q4 2022 Feb 02, 2023	SELL	$21.94 - $26.24 $164,901 - $197,219	-7,516 Reduced 33.23%	15,102 $395,000
Q3 2022 Oct 31, 2022	BUY	$22.0 - $31.87 $145,684 - $211,043	6,622 Added 41.4%	22,618 $505,000
Q2 2022 Jul 29, 2022	SELL	$26.4 - $30.54 $1.32 Million - $1.52 Million	-49,925 Reduced 75.73%	15,996 $477,000
Q1 2022 Apr 29, 2022	BUY	$23.07 - $27.99 $65,403 - $79,351	2,835 Added 4.49%	65,921 $1.73 Million
Q4 2021 Feb 07, 2022	BUY	$21.47 - $32.08 $473,585 - $707,620	22,058 Added 53.76%	63,086 $1.47 Million
Q3 2021 Nov 01, 2021	SELL	$23.37 - $32.13 $840,899 - $1.16 Million	-35,982 Reduced 46.72%	41,028 $1.27 Million
Q2 2021 Aug 12, 2021	BUY	$18.78 - $25.15 $1.08 Million - $1.45 Million	57,744 Added 299.72%	77,010 $1.89 Million
Q1 2021 May 13, 2021	BUY	$18.21 - $23.2 $202,203 - $257,612	11,104 Added 136.05%	19,266 $360,000
Q4 2020 Feb 04, 2021	SELL	$15.39 - $22.1 $1.55 Million - $2.23 Million	-100,965 Reduced 92.52%	8,162 $163,000
Q3 2020 Nov 09, 2020	BUY	$16.16 - $20.66 $1.76 Million - $2.25 Million	109,127 New	109,127 $1.81 Million
Q2 2020 Jul 20, 2020	SELL	$13.31 - $19.41 $113,813 - $165,974	-8,551 Closed	0 $0
Q1 2020 Apr 30, 2020	BUY	$13.06 - $21.24 $44,103 - $71,727	3,377 Added 65.27%	8,551 $123,000
Q4 2019 Jan 28, 2020	SELL	$17.29 - $21.74 $339,679 - $427,104	-19,646 Reduced 79.15%	5,174 $106,000
Q3 2019 Nov 04, 2019	SELL	$19.51 - $24.28 $10,554 - $13,135	-541 Reduced 2.13%	24,820 $484,000
Q2 2019 Jul 29, 2019	SELL	$21.47 - $37.33 $1.65 Million - $2.86 Million	-76,621 Reduced 75.13%	25,361 $572,000
Q1 2019 Apr 29, 2019	BUY	$28.4 - $36.49 $2.56 Million - $3.29 Million	90,066 Added 755.84%	101,982 $3.72 Million
Q4 2018 Feb 01, 2019	SELL	$27.94 - $44.61 $276,550 - $441,549	-9,898 Reduced 45.37%	11,916 $352,000
Q3 2018 Nov 06, 2018	BUY	$38.6 - $46.12 $739,691 - $883,797	19,163 Added 722.86%	21,814 $926,000
Q2 2018 Aug 07, 2018	SELL	$40.56 - $51.36 $112,756 - $142,780	-2,780 Reduced 51.19%	2,651 $109,000
Q1 2018 May 03, 2018	BUY	$53.61 - $67.26 $179,325 - $224,984	3,345 Added 160.35%	5,431 $315,000
Q4 2017 Jan 24, 2018	BUY	$47.69 - $55.39 $99,481 - $115,543	2,086	2,086 $114,000

Others Institutions Holding ALKS

# of Institutions

394

Shares Held

176M

Call Options Held

558K

Put Options Held

427K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.49B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account

Sg Americas Securities, LLC Alkermes Plc. Transaction History